<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The carvacrol (5-isopropyl-2-methylphenol) is a phenolic monoterpene present in EOs of various species especially the Lamiaceae family, which presented pharmacological potentials, such as antioxidant and anti-inflammatory [
 <xref rid="B90" ref-type="bibr" class="xref">90</xref>, 
 <xref rid="B91" ref-type="bibr" class="xref">91</xref>]. The compound was the most reported in the studies included in this article, exhibiting activity in preclinical models of inflammatory diseases of the gastrointestinal tract, such as chemotherapy-induced mucositis and DMH-induced colitis. Its pharmacological activity in the mentioned models is a result of reduced expression of NF-
 <italic class="italic">κ</italic>B, COX-2, and iNOS, associated with decreased levels of IL-1
 <italic class="italic">β</italic>, TNF-
 <italic class="italic">α</italic>, and NO. The treatment was also able to increase the antioxidant enzymes SOD, CAT, MDA, and GSH [
 <xref rid="B47" ref-type="bibr" class="xref">47</xref>, 
 <xref rid="B51" ref-type="bibr" class="xref">51</xref>].
</p>
